MICROBIOLOGY OF CEREBRAL ABSCESSES
2019年7月12日 更新者:Assistance Publique Hopitaux De Marseille
MICROBIOLOGY OF CEREBRAL ABSCESSES (ABCES)
Establish the repertoire of bacteria and Archaea responsible for brain abscesses.
Correlate the microbial repertoire to epidemiological, clinical and radiological data; to define the different nosological entities falling within the framework of cerebral abscesses.
研究概览
详细说明
Brain abscess is a fatal infectious pathology of the central nervous system for which our CHU provides a referent function and supports patients suspected and diagnosed with a cerebral abscess in the area of the regional hospital group (GHT).
Through the routine activity of the Microbiology laboratory of the IHU Méditerranée Infection, more than 180 diagnosed patients have been investigated in 9 years, an average of 20 patients per year.
The mortality of brain abscesses is currently measured at 15% despite well-established diagnostic and therapeutic protocols in the literature, associating surgical drainage of abscess and administration of probabilistic antibiotics.
Our hypothesis is that established protocols take into account incomplete microbiological documentation of cerebral abscesses and therefore anti-infectious therapy that may not be strictly adapted to the causative microorganisms.
Our hypothesis is based on our own work as well as the literature data, showing that current approaches only target bacteria but that these approaches leave aside other living worlds such as Archaea.
Indeed, investigators have recently shown for the first time that methanogens, which are Archaea microorganisms, constitute part of the flora responsible for certain cerebral abscesses and that they have a direct pathogenic role in cerebral abscesses.
More specifically, the diagnosis of cerebral abscess includes several clinical and microbiological situations that are not all of the same therapeutic.
Investigator propose to collect 20 abscesses.
A collection of abscesses is performed systematically during the diagnosis for bacteriological analysis.
There will be no further examination.
The main objective of this clinical research project is to establish the repertoire of microorganisms responsible for brain abscesses; and as a secondary objective to define the different clinical entities forming the cerebral abscesses.
研究类型
观察性的
注册 (预期的)
20
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习联系方式
- 姓名:Alexandra Giuliani
- 电话号码:04 91 38 28 70
- 邮箱:promotion.interne@aphm.fr
研究联系人备份
- 姓名:Didier Raoult
- 电话号码:04 13 73 20 51
- 邮箱:didier.raoult@gmail.com
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
18年 及以上 (成人、年长者)
接受健康志愿者
不
有资格学习的性别
全部
取样方法
概率样本
研究人群
Patient diagnosed with a cerebral abscess at admission; and to benefit from an abscess puncture as part of routine care.
描述
Inclusion Criteria:
- Patient diagnosed with a cerebral abscess at admission; and to benefit from an abscess puncture as part of routine care.
- Affiliate or beneficiary of a social security scheme.
Exclusion Criteria:
- Pregnant or nursing woman.
- Major patient under tutorship or curatorship.
- Patient deprived of liberty or under a court order
- Patient refusing to participate in the study
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Patients with an abscess
Patient diagnosed with a cerebral abscess at admission; and to benefit from an abscess puncture as part of routine care.
|
Investigators propose to collect 20 abscesses.
A collection of abscesses is performed systematically during the diagnostic for bacteriological analysis.
There will be no further examination.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Matrix Assisted Laser Desorption Ionisation - Time of Flight
大体时间:1 day
|
A matrix and a sample are deposited on a target.
Pulsed lasers are fast charging.
|
1 day
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (预期的)
2019年10月1日
初级完成 (预期的)
2022年9月30日
研究完成 (预期的)
2023年10月30日
研究注册日期
首次提交
2019年7月9日
首先提交符合 QC 标准的
2019年7月11日
首次发布 (实际的)
2019年7月12日
研究记录更新
最后更新发布 (实际的)
2019年7月16日
上次提交的符合 QC 标准的更新
2019年7月12日
最后验证
2019年7月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.